|
Azeliragon Clinical Trials
4 actively recruiting trials across 4 locations
Also known as: PF-04494700, TTP488
Los Angeles, California1 trial
Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute
Phase 1/2
Miami, Florida1 trial
Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
Miami Cancer Institute at Baptist Health, Inc.
Phase 1/2
St Louis, Missouri1 trial
Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
Washington University School of Medicine
Early 1
New York, New York1 trial
Concurrent Azeliragon With Craniospinal Irradiation
NYU Langone Health
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.